Add BrightSurf on Google Email

University of California - Los Angeles Health Sciences


UCLA Jonsson Comprehensive Cancer Center scientists identify germline signature that predicts side effects from anti-PD1/PDL1 checkpoint therapy

Researchers have identified a germline biomarker signature that can predict serious side effects in up to 3 in 10 patients undergoing anti-PD1/PDL1 therapy. The findings represent an important step toward personalizing checkpoint therapy, potentially improving patient outcomes and reducing harm.

SourceUniversity of California - Los Angeles Health Sciences·JournalJournal for ImmunoTherapy of Cancer·TypeImaging analysis·DateFeb 3, 2022

UCLA Health team develops new mouse model to shed light on the mystery surrounding Huntington’s disease onset and improve the targeting of potential therapies

Researchers have developed a new mouse model of Huntington's disease that recapitulates more disease-like characteristics than earlier models. The study provides new clues to the mystery surrounding genetic mutations and gives researchers a powerful tool to test new therapies.

SourceUniversity of California - Los Angeles Health Sciences·JournalNeuron·TypeExperimental study·DateFeb 2, 2022

Access to vital health services fell during COVID, particularly for poorer Americans

A UCLA-led study found that Americans' use of common outpatient health services dipped during the COVID-19 pandemic, particularly for those with Medicaid or Medicare-Medicaid dual eligibility insurance. The study suggests that patients may be missing treatments for acute illnesses and delaying preventive care.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA·TypeData/statistical analysis·DateJan 24, 2022

Researchers led by UCLA Health call for more work to address overlooked issues affecting women with Parkinson’s Disease

Researchers identified gaps in care and treatment for women with Parkinson's Disease, highlighting the need for personalized medicine and psychosocial support. The study calls for increased attention to sex and gender differences in PD management.

SourceUniversity of California - Los Angeles Health Sciences·JournalMovement Disorders·TypeCommentary/editorial·DateJan 21, 2022

UCLA-led meta-analysis may help guide treatment planning for patients with high-risk prostate cancer

A UCLA-led meta-analysis of individual patient data from three cohorts found that patients receiving high-dose external beam radiation therapy alone may benefit from longer androgen deprivation therapy (ADT) durations, while those with external beam radiation therapy and brachytherapy boost may be optimally managed with shorter ADT. Th...

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA Oncology·TypeMeta-analysis·DateJan 20, 2022

International meta-analysis quantifies impact of three prostate cancer therapy intensification strategies

A new meta-analysis of randomized clinical trials found that adding androgen deprivation therapy (ADT) to definitive radiotherapy prevents one cancer from metastasizing for every 10 to 15 men treated. Prolonging adjuvant ADT also showed significant benefits, while neoadjuvant ADT was not effective beyond two months.

SourceUniversity of California - Los Angeles Health Sciences·JournalThe Lancet Oncology·TypeMeta-analysis·DateJan 19, 2022

UCLA researchers find that removing brain cells linked to wakefulness and addiction may lessen symptoms of opioid withdrawal

UCLA researchers found that removing brain cells linked to wakefulness and addiction reduces both physical and emotional symptoms of opioid withdrawal. The study suggests that drug therapies regulating hypocretin production may be an effective treatment for opiate addiction and withdrawal.

SourceUniversity of California - Los Angeles Health Sciences·JournalJNeurosci·TypeExperimental study·DateJan 12, 2022

Jonsson Comprehensive Cancer Center researchers identify signaling mechanisms in pancreatic cancer cells that could provide treatment targets

Jonsson Comprehensive Cancer Center researchers have identified signaling mechanisms in pancreatic cancer cells that could be targeted for treatment. By inhibiting a specific protein, cancer cells' DNA can become damaged and induce programmed cell death, providing a potential new strategy for treating this aggressive form of cancer.

SourceUniversity of California - Los Angeles Health Sciences·JournalCell Reports·TypeExperimental study·DateJan 11, 2022

Study: Although they tend to be diagnosed with higher-risk prostate cancer, Black men undergoing radiation therapy have better outcomes than white men

A meta-analysis of seven randomized trials found that Black men with localized prostate cancer had lower recurrence, metastasis, and mortality rates compared to white men. The study challenges the common belief that Black men with prostate cancer have a worse prognosis.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA Network Open·TypeMeta-analysis·DateDec 29, 2021

UCLA Jonsson Comprehensive Cancer Center study details chromosome-level changes that allow melanomas to develop drug resistance

Researchers developed a model of drug resistance in melanoma, revealing mechanisms involving extrachromosomal DNA amplifications and intrachromosomal chromosomal rearrangements. The study found that different forms of DNA offer 'fitness' advantages to tumor cells under varying therapeutic conditions.

SourceUniversity of California - Los Angeles Health Sciences·JournalCancer Discovery·TypeExperimental study·DateDec 20, 2021

UCLA-led study provides first indirect evidence that PSMA PET/CT surpasses conventional imaging in detecting occult prostate cancer spread and predicting long-term course and outcomes

A recent UCLA-led study provided indirect evidence that PSMA PET/CT improves risk-stratification and prognostic capabilities for high-risk prostate cancer patients. The study found that PSMA nomogram outperformed existing tools in predicting clinical outcomes, suggesting its significance in disease course prediction.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA Network Open·TypeObservational study·DateDec 13, 2021

A longer-lasting COVID vaccine? UCLA study points the way

Researchers at UCLA have identified rare T cells capable of targeting a protein found in SARS-CoV-2 and other coronaviruses. By adding a fragment of this protein to vaccines, they hope to create a longer-lasting immune response and increase protection against new variants. This breakthrough could lead to more effective COVID-19 vaccines.

SourceUniversity of California - Los Angeles Health Sciences·JournalCell Reports·TypeExperimental study·DateDec 10, 2021

UCLA research shows why immune checkpoint blockade impedes but does not stop glioblastoma progression

A UCLA research team found that PD-1 blockade initially activates T cells and conventional dendritic cells in glioblastoma, but the immune microenvironment remains dominated by immunosuppressive cells. The study suggests that combining therapies targeting other checkpoint proteins and pathways may improve treatment outcomes.

SourceUniversity of California - Los Angeles Health Sciences·JournalNature Communications·TypeExperimental study·DateNov 29, 2021

New study shows that treating insomnia with cognitive behavioral therapy can prevent major depression in older adults

A new study found that cognitive behavioral therapy (CBT-I) prevented major depression in older adults with insomnia, decreasing the likelihood of depression by over 50%. CBT-I was more effective than sleep education therapy in preventing depression and promoting sustained remission of insomnia.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA Psychiatry·TypeRandomized controlled/clinical trial·DateNov 24, 2021

New imaging technology developed by UCLA research team may reduce need for skin biopsies

A new virtual histology technology may reduce the need for invasive skin biopsies, providing a biopsy-free solution for rapid diagnosis of malignant skin tumors. The technology uses deep-learning frameworks to transform images of intact skin into detailed, virtually stained images.

SourceUniversity of California - Los Angeles Health Sciences·JournalLight Science & Applications·TypeExperimental study·DateNov 18, 2021

UCLA scientists make strides toward an ‘off-the-shelf’ immune cell therapy for cancer

Researchers produce large quantities of powerful cancer-fighting iNKT cells using stem cell engineering and organoid technology, offering a potential solution for mass-producing an off-the-shelf immune cell therapy. The therapy, which uses hematopoietic stem cell-engineered iNKT cells, has been shown to be effective in killing multiple...

SourceUniversity of California - Los Angeles Health Sciences·JournalCell Reports Medicine·TypeExperimental study·DateNov 16, 2021

Discrimination increases risk for mental health issues in young adults

A UCLA study found that young adults experiencing discrimination are at a higher risk for short- and long-term behavioral and mental health problems. The study suggests that the effects of discrimination are connected to disparities in care and institutional discrimination, leading to inequities in diagnoses, treatment, and outcomes.

ASTRO: International meta-analysis quantifies impact of three prostate cancer therapy intensification strategies

A new international meta-analysis of randomized clinical trials found that adding androgen deprivation therapy (ADT) to definitive radiotherapy improves metastasis-free survival by 8% and overall survival by 7%. Prolonging adjuvant ADT for 18-36 months also shows similar benefits.

New study suggests that breastfeeding may help prevent cognitive decline

A new UCLA Health study suggests that breastfeeding may have a positive impact on postmenopausal women's cognitive performance, potentially preventing cognitive decline and Alzheimer's disease. Women who breastfed their babies performed better on cognitive tests compared to those who did not.

SourceUniversity of California - Los Angeles Health Sciences·JournalEvolution Medicine and Public Health·TypeData/statistical analysis·DateOct 22, 2021

A decade after gene therapy, children born with deadly immune disorder remain healthy

Researchers report that 90% of patients who received gene therapy between 2009 and 2012 remain disease-free, with significant immune system differences observed among those treated. The therapy is most effective in younger children, but further work is needed to achieve high levels of gene correction in all patients.

SourceUniversity of California - Los Angeles Health Sciences·JournalBlood·TypeRandomized controlled/clinical trial·DateOct 15, 2021

Vaginal birth may be safer for pregnant women with kidney and liver transplants

A new study found that pregnant women with kidney or liver transplants can safely undergo trial of labor without increased risk to themselves or their babies. In fact, vaginal births resulted in improved outcomes for the baby without compromising maternal health. Conversely, cesarean births were associated with higher risks of complica...

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA·TypeObservational study·DateOct 5, 2021

Black patients’ Lyme disease often diagnosed late, possibly due to missed signs

A UCLA study found that Black patients with Lyme disease are more likely to have neurological complications, such as meningitis and neuropathy, when diagnosed late. The study analyzed data from 2015-16 and found that approximately 1 in 3 Black patients had these complications, compared to less than 1 in 10 white patients.

SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of General Internal Medicine·TypeData/statistical analysis·DateOct 4, 2021

Anti-seizure medication improves cognitive function in some Alzheimer’s patients

A Phase 2 clinical trial found that levetiracetam improved cognitive function in Alzheimer's patients with epileptic activity, particularly those under 65 when symptoms began. The study demonstrated a clear benefit from the medication for this subtype of Alzheimer's disease.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA Neurology·TypeRandomized controlled/clinical trial·DateSep 27, 2021

Important signs of blood clots in the lungs missed in patients with dementia

Patients with dementia presenting with shortness of breath were less likely to be tested for pulmonary embolism compared to those without dementia. Clinical signs and risk factors, such as elevated heart rate, were also evaluated differently in patients with dementia.

SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of the American Geriatrics Society·TypeObservational study·DateSep 20, 2021

ESMO: HER2-targeting antibody-drug improves progression-free survival for women with deadly form of advanced breast cancer

The study found that treating women with HER2 positive metastatic breast cancer with trastuzumab deruxtecan significantly prolongs the length of time the disease is controlled and cancer growth is halted. Patients who received the drug had a 72% improvement in progression-free survival compared to trastuzumab emtansine.

COVID-19 transmission risks rise during labor with patients’ heavier breathing

A new study by UCLA researchers reveals that respiratory emissions produced during labor and vaginal delivery can increase the risk of respiratory disease transmission. The findings support the recommendation of providing full PPE, including N95 masks, to healthcare workers in labor and delivery units to prevent COVID-19 transmission.

SourceUniversity of California - Los Angeles Health Sciences·JournalObstetrics and Gynecology·TypeObservational study·DateSep 14, 2021

Researchers identify a mechanism that can help guide the development of new STING-activating drugs using imaging

A new study found that STING-activating drugs significantly alter nucleotide metabolism in pancreas cancer cells, which can be visualized using [18F]FLT PET imaging. This provides a non-invasive tool to track the effects of these drugs and fine-tune treatments for hard-to-treat cancers.

SourceUniversity of California - Los Angeles Health Sciences·JournalProceedings of the National Academy of Sciences·DateSep 7, 2021

Cost, bleeding cited as major reasons for not taking newer anti-coagulant as prescribed

A recent study found that 26-45% of people with atrial fibrillation fail to adhere to their prescribed direct-acting oral anticoagulants due to cost and bleeding concerns. Researchers interviewed 42 adults who had stopped or reduced dosing, citing these reasons as major barriers to adherence.

SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of the American Geriatrics Society·TypeSurvey·DateSep 2, 2021

Scientists develop brain organoids with complex neural activity

Researchers at UCLA developed brain organoids that mimic human brain structure and function, allowing for the study of neurological disorders like Rett syndrome. The organoids showed organized waves of activity similar to those found in living brains and responded to treatment with an experimental drug.

SourceUniversity of California - Los Angeles Health Sciences·JournalNature Neuroscience·TypeExperimental study·DateAug 23, 2021

Vaping just once raises oxidative stress levels in nonsmokers, increasing disease risk

A new UCLA study found that even one vaping session can significantly increase cellular oxidative stress in healthy younger nonsmokers. The researchers discovered a two- to four-fold increase in oxidative stress levels after a 30-minute vaping session, highlighting the alarming effects of e-cigarettes on young people's health.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA Pediatrics·TypeRandomized controlled/clinical trial·DateAug 9, 2021

Physicians are likelier to test for a particular condition if recent patients they saw were diagnosed with the same thing

A study of 7,400 emergency department physicians found that those who recently saw patients with a pulmonary embolism were 15% more likely to test subsequent patients for the condition. The 'availability heuristic' may influence physicians' care decisions.

SourceUniversity of California - Los Angeles Health Sciences·JournalAnnals of Emergency Medicine·TypeMeta-analysis·DateAug 6, 2021